No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 462 contracts
Samples: Securities Purchase Agreement (Touchpoint Group Holdings Inc.), Securities Purchase Agreement (Can B Corp), Securities Purchase Agreement (Healthcare Integrated Technologies Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 43 contracts
Samples: Securities Purchase Agreement (Tego Cyber, Inc.), Securities Purchase Agreement (Arch Therapeutics, Inc.), Securities Purchase Agreement (Tego Cyber, Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings SEC Documents and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 13 contracts
Samples: Securities Purchase Agreement (Sollensys Corp.), Securities Purchase Agreement (Galaxy Next Generation, Inc.), Securities Purchase Agreement (Galaxy Next Generation, Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off off- balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 11 contracts
Samples: Securities Purchase Agreement (SIMPLICITY ESPORTS & GAMING Co), Securities Purchase Agreement (SIMPLICITY ESPORTS & GAMING Co), Securities Purchase Agreement (SIMPLICITY ESPORTS & GAMING Co)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Material Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 8 contracts
Samples: Securities Purchase Agreement (RespireRx Pharmaceuticals Inc.), Securities Purchase Agreement (RespireRx Pharmaceuticals Inc.), Securities Purchase Agreement (RespireRx Pharmaceuticals Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Exchange Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Mphase Technologies, Inc.), Securities Purchase Agreement (Jerrick Media Holdings, Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings Commission Documents and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 2 contracts
Samples: Convertible Note and Warrant Purchase Agreement (AzurRx BioPharma, Inc.), Convertible Preferred Stock and Warrant (AzurRx BioPharma, Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings SEC Reports and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 2 contracts
Samples: Securities Purchase Agreement (iQSTEL Inc), Securities Purchase Agreement (Snail, Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries subsidiaries and an unconsolidated or other off balance sheet entity that the Company is required to be disclosed by the Company disclose in its 1934 Act filings and is not so disclosed disclosed, or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (FiscalNote Holdings, Inc.)
No Off Balance Sheet Arrangements. There Except as reflected in the SEC Documents, there is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (INVO Bioscience, Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
No Off Balance Sheet Arrangements. There Except as set forth in the SEC Documents, there is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in 13 its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and that is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (RespireRx Pharmaceuticals Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its 1934 β34 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (NuLife Sciences, Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.. β
Appears in 1 contract
Samples: Securities Purchase Agreement (Electromedical Technologies, Inc)
